Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$5,818,452
+$146,956 QoQ
Shares Held
22,910
-1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.14%
of 13F equity value
Holder Rank
#1,502
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Raab & Moskowitz Asset Management LLC holds $28,665,612 across 9 Drug Manufacturers - General names. JNJ ranks #3 (20.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
51,773 | $6,652,830 | |
| 2 | ABBV |
AbbVie Inc.
|
25,628 | $6,449,029 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
22,910 | $5,818,452 | |
| 4 | PFE |
Pfizer Inc
|
226,116 | $5,444,873 | |
| 5 | LLY |
ELI LILLY & Co
|
1,809 | $2,169,769 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
16,300 | $939,206 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,144 | $523,552 | |
| 8 | SNY |
Sanofi
|
9,307 | $397,036 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,818,452 | 22,910 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $5,671,496 | 23,202 | Shares | Sole | 2026-05-21 | |
| 2025-12-31 | $4,974,250 | 24,036 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $4,518,314 | 24,368 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $3,749,859 | 24,549 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,164,242 | 25,110 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,864,246 | 26,720 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $4,553,886 | 28,100 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $4,211,892 | 28,817 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $4,656,797 | 29,438 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,607,999 | 29,399 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $4,631,693 | 29,738 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $4,936,468 | 29,824 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $4,800,350 | 30,970 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,551,049 | 31,424 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $5,145,676 | 31,499 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,731,265 | 32,287 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,691,918 | 32,116 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $5,544,549 | 32,411 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $5,305,921 | 32,854 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $5,642,839 | 34,253 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $5,682,401 | 34,575 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $5,502,162 | 34,961 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,209,757 | 34,993 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,051,429 | 35,920 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,664,687 | 35,573 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||